Latest University of Pennsylvania School Stories
The discovery that high levels of high-density lipoprotein (HDL) cholesterol (the "good cholesterol") is associated with reduced risk of cardiovascular disease has fostered intensive research to modify HDL levels for therapeutic gain.
Given the amount of angst over male pattern balding, surprisingly little is known about its cause at the cellular level.
Implications for blocking metastasis and improving responses to existing therapies.
Weightlifting may play a key role in the prevention of the painful limb-swelling condition lymphedema following breast cancer treatment.
A personalized vaccine is a powerful therapy to prevent recurrence among certain follicular lymphoma patients, according to the latest results of ongoing research led by the University of Pennsylvania School of Medicine.
A new study suggests that skipping breakfast may not change how much food a kid eats throughout the rest of the day.
Taking a cue from the world of business-performance experts and baseball talent scouts, Penn Medicine translational medicine researchers are among the first to find a way to measure the productivity of collaborations in a young, emerging institute.
How a T cell decides to make protein X, Y, or Z can have profound effects for fighting foreign invaders or staving off dire autoimmune reactions.
Crosstalk between ion channels points to new therapeutic strategy, Penn study finds.
Defining of novel mechanism informs understanding of cancer, aging physiology.